RA Capital backs companies turning groundbreaking science into transformative medicines and technologies, investing across biotech R&D, therapeutics, and diagnostics through both hedge and venture funds. Founder Christoph Westphal previously served as CEO of Millennium Pharmaceuticals.
No single defined public exit documented - RA Capital invests across biotech, pharma, diagnostics, and digital health